Cleerly’s Reimbursement Milestone | Spironolactone for Alcohol Use Disorder
Published: October 3, 2022
30th September 2022, Contribution by Bhvita Jani – Featured on CardiacWire.com
… Interventional X-Ray & Mobile C-Arm Rebound: Signify Research reported strong 2021 rebounds in the interventional X-ray (+10.2%) and mobile C-arm (+15.5%) markets following COVID-related declines in 2020. The firm expects the two interventional segments will see continued (but slower) growth through 2026, with interventional X-ray demand driven by structural heart and neurology procedures, and mobile C-arm growth driven by the aging population and increasing awareness of the benefits of minimally invasive procedures….
Click here to read the full article on the Cardiac Wire website…
Share on LinkedIn